News from dsm pharmaceutical products

Dec 03, 2013, 11:00 ET

DSM and Tunitas Therapeutics Sign Agreement to Develop Lead Allergy Therapeutic

The contract covers the initiation of process development activities by DSM for Tunitas' lead Fc-fusion protein for the treatment of asthma and...

Oct 29, 2013, 18:05 ET

DSM Celebrates Opening of New cGMP Facility for Biopharmaceutical Manufacturing in Brisbane, Australia

 DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), today...

Oct 29, 2013, 17:55 ET

DSM and Opthea Sign Agreement to Manufacture Opthea's Lead Product for Eye Disease

 DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it...

Apr 22, 2013, 02:00 ET
DSM Biologics Brisbane (center) adjacent to the Translational Research Institute of Queensland.  (PRNewsFoto/DSM Pharmaceutical Products)

DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia

The DSM facility was built with cooperation from the Queensland and Commonwealth Governments of Australia. Karen King, President of DSM Biologics,...

Apr 22, 2013, 02:00 ET

DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody

 DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it...

Mar 05, 2013, 02:00 ET

DSM signs Master Supply Agreement with Eisai Inc.

 DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE/Euronext: DSM KON), today announced...

Feb 19, 2013, 10:10 ET

DSM and Chemtrix sign collaboration agreement in Continuous Flow Chemistry

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today...

Jan 15, 2013, 02:00 ET

DSM announces license agreement with Amgen for use of DSM's XD® Cell Culture Patents

 Karen King, President of DSM Biologics, commented "We are pleased to enter into this license agreement with Amgen, a global leader in...

Oct 24, 2012, 02:00 ET

DSM Announces Biologics Development and Manufacturing Agreement for Australian Facility

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it...

Jun 19, 2012, 02:00 ET

DSM announces patent grants for proprietary XD® biomanufacturing technology

 DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V. (NYSE, Euronext: DSM KON), announced today...

Jun 18, 2012, 02:00 ET

DSM announces major commercial agreement for services using its XD® Technology

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V. (NYSE, Euronext: DSM KON), announced today that it...

Apr 03, 2012, 02:00 ET

DSM Receives Best Contract Manufacturing Organization Award from Biopharma Asia

 DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V. (NYSE, Euronext: DSM KON) was recognized at...

Mar 13, 2012, 02:30 ET

DSM and Agennix Sign New Contract for Commercial Manufacture of Talactoferrin

 DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V. (NYSE, Euronext: DSM KON), and Agennix AG (Frankfurt Stock...

Jan 31, 2012, 02:00 ET

DSM Announces Marketing and Sales Alliance With Indoco

Royal DSM N.V., (DSM KON: NYSE/Euronext), today announced the signing of an agreement  with Indoco Remedies Limited, Mumbai, India, for...

Dec 13, 2011, 15:15 ET

DSM Signs Contract with QRxPharma to Produce MoxDuo® Capsules

 DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V. (DSM KON: NYSE/Euronext), today announces the signing of a...

Feb 09, 2011, 03:00 ET

DSM Biologics Reports a New Record Achievement with DSM's Proprietary XD® Process Technology with a CHO Cell Line Producing an Fc-fusion Protein:

The achievement was reached using fully chemically-defined media and the CHO cells maintained very high viability throughout the process with 96%...

Feb 09, 2011, 02:00 ET

DSM Recognized With Profiles in Sustainability Award for Corporate Commitment to Sustainability and Innovations for Pharmaceutical Manufacturing

DSM Pharmaceutical Products, the pharmaceutical manufacturing organization within Royal DSM N.V. (DSM KON, Euronext), a global Life Sciences and...

Feb 08, 2011, 02:00 ET

DSM and NKT Therapeutics Sign Contract for Lead Product Development and Manufacture

DSM Biologics, a business unit of DSM Pharmaceutical Products, today announced the signing of a contract with NKT Therapeutics, Inc. based in...

Jan 27, 2011, 02:00 ET

DSM Joins International Response to Flooding in Australia

Significant flooding occurred in many areas of Queensland during late December 2010 and early January 2011.  Thousands of residents were...

Jan 12, 2011, 08:00 ET

DSM and Codexis Sign Enzyme Supply Agreement

The agreement grants DSM rights to use Codexis' custom biocatalysts and services, and secures supply of Codexis enzymes for commercialization of...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge